New FDA Warnings for Deep Vein Thrombosis
and Pulmonary Embolism
Low-T Testosterone Drugs Such as AndroGel Linked to Increased Heart Attack, Stroke and Blood Clot Risk
AndroGel Blood Clots
Testosterone Lawsuits Filed Over Failure to Warn Users of Drug Dangers
AndroGel Blood Clots
Testosterone Lawsuit Information and Free Consultation with a Testosterone Attorney

No-Cost, No-Obligation
AndroGel Testosterone
Lawsuit Case Review


Bookmark and Share

Testosterone Heart Attack Lawsuit Center

AndroGel Lawsuits - Attorneys Handling Testosterone Lawsuits for Heart Attack and Stroke Provide Free, No-Obligation AndroGel Lawsuit Evaluation

AndroGel Lawyer

Testosterone replacement therapy increases men’s risk of a serious cardiac event including heart attack and stroke by two to three times. Lawyers handling AndroGel testosterone lawsuits say AbbVie and other drug companies made false claims about the product’s efficacy and glossed over the dangers of heart attack and stroke. Many men taking testosterone drugs such as AndroGel are doing so based on unproven advertising claims that hormone replacement therapy can offset normal aspects of aging.

Endocrinologists caution that a majority of men taking AndroGel do not have genuine hypogonadism, the condition for which testosterone therapy is medically indicated. Using testosterone replacement therapy without medical indication exposes men to severe and fatal risks without the promise of scientifically-proven advantages. AndroGel lawsuits allege that men taking testosterone drugs were not adequately warned of the potential for heart attack and stroke.

Filing a testosterone lawsuit may be the most effective method for consumers to demand corporate accountability for the injustices done to men who have had heart attacks or strokes while taking AndroGel. If you or a man in your family suffered from a serious cardiac problem while using a testosterone supplement, AndroGel attorneys believe you may be eligible to file a claim for damages, harm, or loss suffered as a result of a heart attack or stroke. The AndroGel Testosterone Lawsuits website brings needed information to the public on heart attack and stroke claims, including information on testosterone FDA warnings, how to choose an AndroGel heart attack or stroke lawyer, and how to file a testosterone stroke or heart attack lawsuit.


Testosterone Lawyer Heart Attack and Stroke

AndroGel Lawsuits

Individuals who have suffered stroke, heart attack, or other cardiac problems while taking AndroGel or a similar testosterone product may qualify to file an AndroGel lawsuit. A group of men filed testosterone lawsuits in early 2014 against AbbVie, saying the drug maker failed to warn consumers of heart attack and stroke risks. Persons filing AndroGel lawsuits can expect real compensation for the damages and loss caused by stroke and heart attack. This page features information on finding a lawyer and filing a testosterone lawsuit.



Testosterone Lawyers FAQ

AndroGel Lawsuit FAQs

The AndroGel Lawsuit FAQs page features answers to common questions regarding claims for heart attack and stroke. Many families wonder who qualifies to file a testosterone lawsuit and what kind of compensation can be expected from heart attack and stroke claims.. Filing a testosterone claim can help increase pharmaceutical company accountability, and provides meaningful compensation for men and the families of men who have been harmed by testosterone products. This page provides information about testosterone lawsuit time limits that may apply in your state.



Unaware of Cardiac Risks, More Men Are Taking Testosterone Supplements than Ever Before

Prescriptions for AndroGel and other testosterone-boosting drugs have been on the rise in the United States for the past decade. The number of testosterone prescribers has tripled since 2001, in large part thanks to aggressive marketing campaigns that prey on men’s natural anxieties over aging. The “disease awareness” marketing campaigns for “Low-T” reach far beyond the FDA approval for hypogonadism, encouraging men with slight ailments to self-diagnose and request a prescription. Today, testosterone products are among the most prescribed drugs around the globe, yielding billions in profits to large pharmaceutical corporations. Three million American men prescribed to AndroGel alone during 2012. Total U.S. sales of testosterone supplements exceeded $2 billion in 2012, and are expected to grow to $5 billion by 2017.

Hypogonadism, the only condition for which AndroGel has been approved, is characterized by a severe lack of natural serum testosterone, must be diagnosed via blood tests, and can result in significant health problems.Researchers say as many as 50% of men taking testosterone have never been tested for low testosterone. Millions of men throughout the nation may be taking AndroGel and similar drugs unnecessarily.

AndroGel lawsuits assert that the drug makers have not adequately warned consumers of the testosterone heart attack and stroke risks, despite the existence of research proving the AndroGel heart attack link. Endocrinology experts say advertising budgets to promote testosterone replacement therapies far outweigh money spent on research of testosterone risks. Testosterone products are now the subject of warnings from the FDA and Consumer Reports based on heart attack and stroke risks.

FDA Testosterone Warning

FDA Testosterone Warning Prompts Lawsuits

FDA AndroGel Warning Prompts Lawsuits On January 31, 2014, a FDA testosterone warning for heart attack and stroke risks. The warning was issued on the basis of new research in late 2013 and early 2014, confirming earlier findings that taking AndroGel increases a man’s risk for heart attack and stroke as much as two or three times the ordinary rate. While the FDA testosterone warning does not say patients should stop taking the drug, it does caution clinicians to carefully consider the drug’s side effects before prescribing AndroGel. In many cases, the cardiac risks posed by the medication may vastly outweigh potential benefits. In the days following the release of the FDA AndroGel Warning, numerous lawsuits were filed against AbbVie, asserting that patients who have suffered from stroke or heart attack were not warned of the cardiac risks posed by the drug. In many cases, men may have chosen not to take testosterone if they had known it posed fatal health risks.

FDA Issues Additional Testosterone Warning June 19, 2014

The FDA is now requiring testosterone drugs like AndroGel, AndroDerm, Axiron, Testim and others to carry a warning for blood clots in the veins, which can result in deep vein thrombosis and pulmonary embolism.    The attorneys at The Onder Law Firm handling AndroGel Lawsuits and other testosterone litigation have spoken with hundreds of testosterone users and their families whom have suffered serious adverse cardiovascular events, including death.  This FDA Testosterone Warning comes too late for thousands, possibly tens of thousands of users, but lawsuits against these drug manufacturers may serve to change the marketing of dangerous drugs that produce billions in annual sales at the ultimate expense of families.